Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple Sclerosis
Clinical trial NCT06644638 · COMPLETED
Trial details
- NCT number
- NCT06644638
- Sponsor
- Novartis
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-15
- Primary completion
- 2023-10-30
- Enrollment
- 3632
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.